Galmed Pharmaceuticals Ltd. Ordinary Shares — Institutional Ownership
Which tracked institutions hold GLMD, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
2
Funds holding
$84
Total value held
Selling
0 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | $77 | 157 | -141 | -47.32% |
| 2 | Wells Fargo & Company/Mn | $7 | 9 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.